GSK3145095
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3145095, covering 2020-07-31 to 2020-07-31. Get the full timeline:
Most recent: Clinical Trial Update: First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors [Phase 2]